BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Peijia Medical Announces 2024 Interim Results

  August 26, 2024

   · 

  6 min read
• Press Releases

  Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

  August 26, 2024

   · 

  3 min read
• 

  IPO

  MBX Unveils Plans for Nasdaq Debut, Joins Two Other IPO Hopefuls

  MBX Biosciences follows Bicara Therapeutics and Zenas Biopharma, which also announced last week their respective plans to go public in a potential boost to the recent slump in the IPO market.

  August 26, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Layoffs

  Bayer to Lay Off 150 in Basel, Switzerland

  The Switzerland layoffs are the latest in Bayer’s 2024 workforce reductions, which already include 1,500 people and nearly half of the executive leadership team.

  August 26, 2024

   · 

  1 min read

   · 

  Angela Gabriel
• Press Releases

  Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

  August 26, 2024

   · 

  3 min read
• Press Releases

  Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

  August 26, 2024

   · 

  2 min read
• Press Releases

  Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024

  August 26, 2024

   · 

  3 min read
• Press Releases

  Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference

  August 26, 2024

   · 

  1 min read
• Press Releases

  Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11

  August 26, 2024

   · 

  5 min read
• Press Releases

  Dewpoint Therapeutics Awarded Target ALS Grant for the Second Time for Development of c-mods for Amyotrophic Lateral Sclerosis (ALS)

  August 26, 2024

   · 

  4 min read